Modeling operational quality metrics and costs of long-acting antibiotics for acute bacterial skin and skin structure infection treatment in the emergency department

References

• Peterson RA, Polgreen LA, Cavanaugh JE, et al. Increasing incidence, cost, and seasonality in patients hospitalized for cellulitis. Open Forum Infect Dis. 2017;4:ofx008
   PubMed Web of Science ®Google Scholar
• Kaye KS, Patel DA, Stephens JM, et al. Rising United States hospital admissions for acute bacterial skin and skin structure infections: recent trends and economic impact. PLoS One. 2015;10:e0143276.
   PubMed Web of Science ®Google Scholar
• Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006;355:666–674.
   PubMed Web of Science ®Google Scholar
• Talan DA, Salhi BA, Moran GJ, et al. Factors associated with decision to hospitalize emergency department patients with skin and soft tissue infection. West J Emerg Med. 2015;16:89–97.
   PubMed Web of Science ®Google Scholar
• Cosgrove SE, Carmeli Y. The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis. 2003;36:1433–1437.
   PubMed Web of Science ®Google Scholar
• Foley M, Kifaieh N, Mallon WK. Financial impact of emergency department crowding. West J Emerg Med. 2011;12:192–197.
   PubMedGoogle Scholar
• Sorup CM, Jacobsen P, Forberg JL. Evaluation of emergency department performance – a systematic review on recommended performance and quality-in-care measures. Scand J Trauma Resusc Emerg Med. 2013;21:62.
   PubMed Web of Science ®Google Scholar
• Ektare V, Khachatryan A, Xue M, et al. Assessing the economic value of avoiding hospital admissions by shifting the management of gram + acute bacterial skin and skin-structure infections to an outpatient care setting. J Med Econ. 2015;18:1092–1101.
   PubMed Web of Science ®Google Scholar
• Centers for Medicare and Medicaid Services. Medicare.gov [Internet]. 2014 [cited 2014 March 4]. Available from: http://www.medicare.gov/hospitalcompare/
   Google Scholar
• Vancocin HCl (vancomycin hydrochloride for injection USP). Full Prescribing Information. Baudette (MN): ANI Pharmaceuticals Inc.; 2017.
   Google Scholar
• Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. Clin Infect Dis. 2014;59:e10–e52.
   PubMed Web of Science ®Google Scholar
• Ross MA, Hockenberry JM, Mutter R, et al. Protocol-driven emergency department observation units offer savings, shorter stays, and reduced admissions. Health Aff. 2013;32:2149–2156.
   Web of Science ®Google Scholar
• Pollack CV Jr, Amin A, Ford WT Jr, et al. Acute bacterial skin and skin structure infections (ABSSSI): practice guidelines for management and care transitions in the emergency department and hospital. J Emerg Med. 2015;48:508–519.
   PubMed Web of Science ®Google Scholar
• Gunderson CG, Cherry B, Fisher A. Mortality of hospitalized patients with cellulitis: a systematic review and meta-analysis. Presented at: Hospital Medicine. 2018 Apr 8–11; Orlando (FL).
   Google Scholar
• Dalvance (dalbavancin). Full Prescribing Information. Parsippany (NJ): Durata Therapeutics US Ltd; 2018.
   Google Scholar
• Xydalba (dalbavancin). Full Prescribing Information. Amsterdam (Netherlands): Durata Therapeutics International BV; 2016.
   Google Scholar
• Revankar N, Ward AJ, Pelligra CG, et al. Modeling economic implications of alternative treatment strategies for acute bacterial skin and skin structure infections. J Med Econ. 2014;17:730–740.
   PubMedGoogle Scholar
• Caro JJ, Moller J, Getsios D. Discrete event simulation: the preferred technique for health economic evaluations? Value Health. 2010;13:1056–1060.
   PubMed Web of Science ®Google Scholar
• York Health Economics Consortium. Discrete Event Simulation [Internet]. York, UK: 2016 [cited 2019 Feb 15]. Available from: https://www.yhec.co.uk/glossary/discrete-event-simulation/
   Google Scholar
• Standfield LB, Comans TA, Scuffham PA. An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting. Eur J Health Econ. 2017;18:33–47.
   PubMed Web of Science ®Google Scholar
• Day TE, Al-Roubaie AR, Goldlust EJ. Decreased length of stay after addition of healthcare provider in emergency department triage: a comparison between computer-simulated and real-world interventions. Emerg Med J. 2013;30:134–138.
   PubMed Web of Science ®Google Scholar
• Morgareidge D, Cai H, Jia J. Performance-driven design with the support of digital tools: applying discrete event simulation and space syntax on the design of the emergency department. Front Architectural Res. 2014;3:250–264.
   Google Scholar
• Sulham K, Fan W, Werner R. Real-world prescribing patterns for the treatment of acute bacterial skin and skin structure infections in the United States: a retrospective database analysis. Value Health. 2015;18:A1–A307.
   PubMed Web of Science ®Google Scholar
• Mistry RD, Shapiro DJ, Goyal MK, et al. Clinical management of skin and soft tissue infections in the U.S. emergency departments. West J Emerg Med. 2014;15:491–498.
   PubMedGoogle Scholar
• Lipsky BA, Moran GJ, Napolitano LM, et al. A prospective, multicenter, observational study of complicated skin and soft tissue infections in hospitalized patients: clinical characteristics, medical treatment, and outcomes. BMC Infect Dis. 2012;12:227.
   PubMed Web of Science ®Google Scholar
• Wang J, Li J, Tussey K, et al. Reducing length of stay in emergency department: a simulation study at a community hospital. IEEE Trans Syst Man Cybern A. 2012;42:1314–1322.
   Web of Science ®Google Scholar
• Analysis of American Hospital Association Annual Survey data, 2014, for community hospitals [Internet]. 2014 [cited 2014 Jul 1]. Available from: https://www.ahadataviewer.com/additional-data-products/aha-survey/
   Google Scholar
• Rui P, Kang K, Albert M. National Hospital Ambulatory Medical Care Survey: 2013 Emergency Department Summary Tables [Internet]. 2013 [cited 2019 Feb 18]. Available from: http://www.cdc.gov/nchs/data/ahcd/nhamcs_emergency/2013_ed_web_tables.pdf
   Google Scholar
• US Census Bureau. Annual Estimates of the Resident Population: for Selected Age Groups by Sex for the United States, States, Counties, and Puerto Rico Commonwealth and Municipios: April 1, 2010 to July 1, 2014 [Internet]. 2015. [cited 2019 Feb 18]. Available from: https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?pid=PEP_2017_PEPANNRES&src=pt
   Google Scholar
• Shaikh SB, Jerrard DA, Witting MD, et al. How long are patients willing to wait in the emergency department before leaving without being seen? West J Emerg Med. 2012;13:463–467.
   PubMedGoogle Scholar
• Orbactiv (oritavancin). Full Prescribing Information. Lincolnshire (IL): Melinta Therapeutics Inc.; 2018.
   Google Scholar
• Centers for Disease Control and Prevention. Quick stats: median emergency department (ED) wait and treatment times, by triage level – National Hospital Ambulatory Medical Care Survey, United States, 2010–2011. Morb Mortal Wkly Rep. 2014;63:421–440.
   PubMed Web of Science ®Google Scholar
• Udeze C, Bookstaver B, Liu Y, et al. Hospital admission and unplanned revisits in patients with ABSSSIs. Presented at: Academy of Managed Care Pharmacy Nexus. 2016 Oct 3–6; National Harbor (MD).
   Google Scholar
• Brenner S, Zeng Z, Liu Y, et al. Modeling and analysis of the emergency department at University of Kentucky Chandler Hospital using simulations. J Emerg Nurs. 2010;36:303–310.
   PubMed Web of Science ®Google Scholar
• Jerardi KE, Auger KA, Shah SS, et al. Discordant antibiotic therapy and length of stay in children hospitalized for urinary tract infection. J Hosp Med. 2012;7:622–627.
   PubMed Web of Science ®Google Scholar
• Truven Red Book Online 2.0. [Internet] [cited 2017 June 22]. Available from: http://truvenhealth.com/Products/Micromedex
   Google Scholar
• Lodise TP, Fan W, Sulham KA. Economic impact of oritavancin for the treatment of acute bacterial skin and skin structure infections in the emergency department or observation setting: cost savings associated with avoidable hospitalizations. Clin Ther. 2016;38:136–148.
   PubMed Web of Science ®Google Scholar
• Tice AD, Turpin RS, Hoey CT, et al. Comparative costs of ertapenem and piperacillin–tazobactam in the treatment of diabetic foot infections. Am J Health Syst Pharm. 2007;64:1080–1086.
   PubMed Web of Science ®Google Scholar
• Shah NP, Reddy P, Paladino JA, et al. Direct medical costs associated with using vancomycin in methicillin-resistant Staphylococcus aureus infections: an economic model. Curr Med Res Opin. 2004;20:779–790.
   PubMed Web of Science ®Google Scholar
• De Cock E, Sorensen S, Levrat F, et al. Cost-effectiveness of linezolid versus vancomycin for hospitalized patients with complicated skin and soft-tissue infections in France. Med Mal Infect. 2009;39:330–340.
   PubMed Web of Science ®Google Scholar
• Bounthavong M, Hsu DI. Cost-effectiveness of linezolid in methicillin-resistant Staphylococcus aureus skin and skin structure infections. Expert Rev Pharmacoecon Outcomes Res. 2012;12:683–698.
   PubMed Web of Science ®Google Scholar
• Stephens JM, Gao X, Patel DA, et al. Economic burden of inpatient and outpatient antibiotic treatment for methicillin-resistant Staphylococcus aureus complicated skin and soft-tissue infections: a comparison of linezolid, vancomycin, and daptomycin. Clinicoecon Outcomes Res. 2013;5:447–457.
   PubMedGoogle Scholar
• Jensen IS, Lodise TP, Fan W, et al. Use of oritavancin in acute bacterial skin and skin structure infections patients receiving intravenous antibiotics: a US hospital budget impact analysis. Clin Drug Investig. 2016;36:157–168.
   PubMed Web of Science ®Google Scholar
• Izadpanah M, Khalili H. Antibiotic regimens for treatment of infections due to multidrug-resistant gram-negative pathogens: an evidence-based literature review. J Res Pharm Pract. 2015;4:105–114.
   PubMed Web of Science ®Google Scholar
• LaPensee KT, Fan W. Economic burden of hospitalization with antibiotic treatment for bacteremia/sepsis in the US. Presented at: IDWeek Annual Meeting. 2012 Oct 17–21; San Diego (CA).
   Google Scholar
• Almarzoky Abuhussain SS, Burak MA, Kohman KN, et al. Patient preferences for treatment of acute bacterial skin and skin structure infections in the emergency department. BMC Health Serv Res. 2018;18:932.
   PubMed Web of Science ®Google Scholar
• Keyloun KR, Gillard P, Zhao Q, et al. Hospital cost and reimbursement for acute bacterial skin and skin structure infections: a retrospective observational analysis of admissions using 2014 Medicare claims data. Open Forum Infect Dis. 2016;3:1145.
   Google Scholar